DASATINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 168 adverse event reports in the FDA FAERS database where DASATINIB was used for Neoplasm malignant.
Most Reported Side Effects for DASATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Pleural effusion | 2,424 | 8.1% | 96 | 840 |
| Fatigue | 2,173 | 7.2% | 18 | 286 |
| Death | 1,741 | 5.8% | 1,735 | 110 |
| Nausea | 1,740 | 5.8% | 34 | 251 |
| Diarrhoea | 1,728 | 5.8% | 34 | 299 |
| Headache | 1,625 | 5.4% | 23 | 170 |
| Adverse event | 1,382 | 4.6% | 13 | 261 |
| Rash | 1,300 | 4.3% | 25 | 150 |
| Drug ineffective | 1,271 | 4.2% | 72 | 173 |
| Hospitalisation | 1,181 | 3.9% | 21 | 1,150 |
| Dyspnoea | 1,180 | 3.9% | 35 | 363 |
| Off label use | 1,045 | 3.5% | 132 | 226 |
| Pulmonary oedema | 873 | 2.9% | 24 | 335 |
| Vomiting | 714 | 2.4% | 33 | 196 |
| Drug intolerance | 684 | 2.3% | 10 | 70 |
Other Indications for DASATINIB
Chronic myeloid leukaemia (15,612)
Product used for unknown indication (6,986)
Acute lymphocytic leukaemia (2,255)
Leukaemia (654)
Myeloid leukaemia (411)
Acute myeloid leukaemia (315)
Philadelphia positive acute lymphocytic leukaemia (237)
Philadelphia chromosome positive (191)
Chronic lymphocytic leukaemia (156)
Philadelphia positive chronic myeloid leukaemia (141)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)